AbbVie Sees FY2026 Adj. Diluted EPS $13.91-$14.11 Including Q2 IPR&D Expense - SEC Filing
* Sees Q2 Adj. Diluted EPS $3.57-$3.61 Including IPR&D Expense * Q2 Includes $291M Bought IPR&D Expense, Impacting GAAP And Adj. Diluted EPS By $0.17
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.